Mark J. Krantz
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Immunotherapy and Immune Responses, Radiopharmaceutical Chemistry and Applications, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins(1976)333 cited
- → Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2(1998)300 cited
- → Attachment of thioglycosides to proteins: enhancement of liver membrane binding(1976)164 cited
- Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation.(1998)
- → Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment(2006)145 cited
- → Dopamine-β-Hydroxylase: A Tetrameric Glycoprotein(1973)140 cited
- → A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS(2011)136 cited
- → Liposomal Formulations of Synthetic MUC1 Peptides: Effects of Encapsulation versus Surface Display of Peptides on Immune Responses(1998)95 cited
- → Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer(2001)81 cited
- → Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine(1998)74 cited